Torrent Pharmaceuticals Ltd (TORNTPHARM):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Torrent Pharmaceuticals Ltd (TORNTPHARM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10133
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:47
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Torrent Pharmaceuticals Ltd (Torrent) manufactures and markets branded and unbranded generic pharmaceuticals. It provides products in cardiovascular, central nervous system, gastro-intestinal, diabetology, anti-infective and pain management segments. Also, the company has presence in nephrology, cancer, gynecology and pediatric segments. Torrent has a fully equipped research center that is approved by the US FDA and various other regulatory authorities and manufacturing facilities at Indrad, Baddi, Sikkim, Dahej and Pithampur. The company has presence in more than forty countries worldwide and has wholly owned subsidiaries in USA, the UK, Germany, Russia, Brazil, Mexico, Philippines and other major markets. Torrent is headquartered in Ahmedabad, Gujarat, India.

Torrent Pharmaceuticals Ltd (TORNTPHARM) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Torrent Pharma Acquires Branded Business from Unichem Labs for USD556.6 Million 13
Torrent Pharma Acquires Two Brands of Women Healthcare Segment from Novartis 15
Torrent Pharma Acquires Active Pharmaceutical Ingredients Manufacturing Unit in Vizag from Glochem Industries 16
Torrent Pharma to Acquire Minocycline Tablet From Ranbaxy Labs 17
Torrent Pharma Completes Acquisition Of Formulations Business Of Elder Pharma For US$333 Million 18
Private Equity 20
ChrysCapital Acquires 3% Stake In Torrent Pharma For US$40 Million 20
Partnerships 21
Navamedic Enters Into Distribution Agreement With Torrent Pharma 21
Licensing Agreements 22
Torrent Pharma Enters into Licensing Agreement with Reliance Life Sciences 22
Equity Offering 23
Torrent Pharma May Raise USD231 Million in Private Placement of Share 23
Torrent Pharma Plans to Raise up to USD782 Million in Private Placement of Securities 24
Vista Pharma to Raise Funds through Public Offering of Shares and Warrants 25
Torrent Pharma Plans Private Placement of Shares for USD488.2 Million 26
Debt Offering 27
Torrent Pharma Plans to Raise up to USD1.95 Billion in Private Placement of Debt Securities 27
Torrent Pharma Raises USD155 Million in Private Placement of 7.98% Debentures Due 2025 28
Torrent Pharma Plans Private Placement of Bonds for USD1.22 Billion 29
Acquisition 30
Torrent Pharma Acquires Bio-Pharm 30
ChrysCapital Divests Stake in Torrent Pharma 31
Torrent Pharma Acquires Zyg Pharma 32
Torrent Pharma Plans To Acquire Pharma Companies 33
Torrent Pharmaceuticals Ltd – Key Competitors 34
Torrent Pharmaceuticals Ltd – Key Employees 35
Torrent Pharmaceuticals Ltd – Locations And Subsidiaries 36
Head Office 36
Other Locations & Subsidiaries 36
Recent Developments 39
Financial Announcements 39
Nov 03, 2018: Torrent Pharma Q2 net drags 12% to Rs 1.7 bn on rupee decline, US recall 39
Jul 31, 2017: Torrent Pharma announces Q1 FY 2017-18 Results 40
May 26, 2017: Torrent Pharmaceuticals Reports Revenue Of INR19.8 Billion In Fiscal 2017 42
Corporate Communications 43
Aug 31, 2018: Torrent Pharmaceuticals: Intimation of change in Chief Financial Officer 43
Jul 26, 2018: Torrent Pharmaceuticals: Intimation of cessation of director of the company 44
Jul 22, 2017: Torrent Pharmaceuticals : Intimation of Resignation of Director of the Company 45
Product News 46
Aug 23, 2018: Torrent Pharmaceuticals limited issues voluntary nationwide recall of Valsartan/Amlodipine/HCTZ, Valsartan/Amlodipine and Valsartan Tablets 46
Appendix 47
Methodology 47
About GlobalData 47
Contact Us 47
Disclaimer 47

List of Tables
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Torrent Pharmaceuticals Ltd, Deals By Therapy Area, 2012 to YTD 2018 9
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Torrent Pharma Acquires Branded Business from Unichem Labs for USD556.6 Million 13
Torrent Pharma Acquires Two Brands of Women Healthcare Segment from Novartis 15
Torrent Pharma Acquires Active Pharmaceutical Ingredients Manufacturing Unit in Vizag from Glochem Industries 16
Torrent Pharma to Acquire Minocycline Tablet From Ranbaxy Labs 17
Torrent Pharma Completes Acquisition Of Formulations Business Of Elder Pharma For US$333 Million 18
ChrysCapital Acquires 3% Stake In Torrent Pharma For US$40 Million 20
Navamedic Enters Into Distribution Agreement With Torrent Pharma 21
Torrent Pharma Enters into Licensing Agreement with Reliance Life Sciences 22
Torrent Pharma May Raise USD231 Million in Private Placement of Share 23
Torrent Pharma Plans to Raise up to USD782 Million in Private Placement of Securities 24
Vista Pharma to Raise Funds through Public Offering of Shares and Warrants 25
Torrent Pharma Plans Private Placement of Shares for USD488.2 Million 26
Torrent Pharma Plans to Raise up to USD1.95 Billion in Private Placement of Debt Securities 27
Torrent Pharma Raises USD155 Million in Private Placement of 7.98% Debentures Due 2025 28
Torrent Pharma Plans Private Placement of Bonds for USD1.22 Billion 29
Torrent Pharma Acquires Bio-Pharm 30
ChrysCapital Divests Stake in Torrent Pharma 31
Torrent Pharma Acquires Zyg Pharma 32
Torrent Pharma Plans To Acquire Pharma Companies 33
Torrent Pharmaceuticals Ltd, Key Competitors 34
Torrent Pharmaceuticals Ltd, Key Employees 35
Torrent Pharmaceuticals Ltd, Other Locations 36
Torrent Pharmaceuticals Ltd, Subsidiaries 36

List of Figures
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

★海外企業調査レポート[Torrent Pharmaceuticals Ltd (TORNTPHARM):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The SPAR Group Limited:戦略・SWOT・企業財務分析
    The SPAR Group Limited - Strategy, SWOT and Corporate Finance Report Summary The SPAR Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Fera Pharmaceuticals LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Fera Pharmaceuticals LLC (Fera) is a pharmaceutical company that develops, markets and commercializes ointments and medicines. The company offers neptazane, bacitracin ophthalmic ointment USP, neo-polycin HC, and others. It offers various treatment options for patient and healthcare communit …
  • Taylor Communications Inc:企業の戦略的SWOT分析
    Taylor Communications Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Inhibrx LP:製薬・医療:M&Aディール及び事業提携情報
    Summary Inhibrx LP (Inhibrx) is a biotherapeutic company that develops drugs for treatment of oncology, infectious disease and inflammatory diseases. The company’s products include therapeutic proteins with multivalent and multi specific molecules which are designed from their antibody technology. I …
  • Marshall of Cambridge (Holdings) Ltd:企業の戦略的SWOT分析
    Marshall of Cambridge (Holdings) Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Diazyme Laboratories Inc:企業の製品パイプライン分析2018
    Summary Diazyme Laboratories Inc (Diazyme Laboratories) is a diagnostic reagents developer. The company offers test kits for diagnosis of cardiovascular disease, liver disease, cancer markers, renal disease, diabetes, and electrolytes. It offers products by markers, instrument specific packaging, po …
  • Lonestar Resources US Inc (LONE):石油・ガス:M&Aディール及び事業提携情報
    Summary Lonestar Resources US Inc (Lonestar) is an independent oil and gas company that focuses on acquisition, exploration, development and production of oil and natural gas resources. Lonestar holds majority of the working interests in its properties and manages activities related to designing and …
  • Sunflower Electric Power Corporation:企業の戦略的SWOT分析
    Sunflower Electric Power Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Catholic Health Initiatives:企業の戦略・SWOT・財務情報
    Catholic Health Initiatives - Strategy, SWOT and Corporate Finance Report Summary Catholic Health Initiatives - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Steatite Limited:企業の戦略・SWOT・財務情報
    Steatite Limited - Strategy, SWOT and Corporate Finance Report Summary Steatite Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Kubota Corporation (6326):企業の財務・戦略的SWOT分析
    Kubota Corporation (6326) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • MolMed SpA (MLM):企業の財務・戦略的SWOT分析
    Summary MolMed SpA (Molmed) is a biotechnology company which offers research, development, manufacturing and clinical validation of novel anticancer therapies. Its pipeline antitumour products include Zalmoxis (TK), a cell based therapy enabling bone marrow transplants donors for the treatment of hi …
  • Ferrovial SA (FER):企業の財務・戦略的SWOT分析
    Ferrovial SA (FER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Towngas China Co Ltd (1083):企業の財務・戦略的SWOT分析
    Summary Towngas China Co Ltd (Towngas China), a subsidiary of The Hong Kong and China Gas Co Ltd is an oil and gas company. The company's business activities include sale and distribution of pipeline gas, gas pipeline construction, operation of city-gas pipeline networks, operating fuel automobile r …
  • Polskie Sieci Elektroenergetyczne SA:企業の戦略的SWOT分析
    Polskie Sieci Elektroenergetyczne SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • FMC Corp (FMC):企業の財務・戦略的SWOT分析
    FMC Corp (FMC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Bank of China Ltd:戦略・SWOT・企業財務分析
    Bank of China Ltd - Strategy, SWOT and Corporate Finance Report Summary Bank of China Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Gencor Industries Inc (GENC):企業の財務・戦略的SWOT分析
    Gencor Industries Inc (GENC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • BEML Ltd:企業の戦略・SWOT・財務分析
    BEML Ltd - Strategy, SWOT and Corporate Finance Report Summary BEML Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • EyePoint Pharmaceuticals Inc (PSDV):医療機器:M&Aディール及び事業提携情報
    Summary EyePoint Pharmaceuticals Inc (EyePoint), formerly pSivida Corp, is a biopharmaceutical company that provides development of miniaturized, sustained-release drug delivery products and technologies. The company offers products such as iluvien, retisert and durasert, among others. Its durasert …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆